Related Experiment Video
Updated: Jun 7, 2026

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
[Mitotane in the treatment of adrenal carcinoma]
1HYKS:n endokrinologian klinikka, PL 340, 00029 HUS.
Abstract:
Mitotane has been used for 50 years as the first-line drug in the treatment of disseminated adrenocortical carcinoma. It reduces local recurrence of the disease and development of metastases even after a seemingly total surgical removal of the tumor. The use of mitotane has been hampered by its copious adverse effects. Its use requires knowledge of the properties and biological effects of the product. Determination of plasma levels of mitotane will help in carrying out the treatment. The dosage can be optimized and the drug's adverse effects avoided by monitoring the plasma level.
Related Concept Videos
Tumor Immunotherapy
Treatment Resistant Cancers

